BACK (IMAC Holdings) Retained Earnings: $-72.38 Mil (As of Sep. 2025)


What is IMAC Holdings Retained Earnings?

IMAC Holdings BACK Retained Earnings is $-72.38 Mil as of Sep. 2025. The stock has 7 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. IMAC Holdings's retained earnings for the quarter that ended in Sep. 2025 was $-72.38 Mil.

IMAC Holdings's quarterly retained earnings declined from Mar. 2025 ($-67.18 Mil) to Jun. 2025 ($-69.30 Mil) and declined from Jun. 2025 ($-69.30 Mil) to Sep. 2025 ($-72.38 Mil).

IMAC Holdings's annual retained earnings declined from Dec. 2022 ($-46.52 Mil) to Dec. 2023 ($-55.94 Mil) and declined from Dec. 2023 ($-55.94 Mil) to Dec. 2024 ($-64.98 Mil).

IMAC Holdings  (OTCPK:BACK) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

IMAC Holdings Retained Earnings Historical Data

* Premium members only.

The historical data trend for IMAC Holdings's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IMAC Holdings Retained Earnings Chart

IMAC Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Retained Earnings
Get a 7-Day Free Trial Premium Member Only -17.67 -28.21 -46.52 -55.94 -64.98

IMAC Holdings Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -59.93 -64.98 -67.18 -69.30 -72.38

IMAC Holdings Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of $-72.38 Mil mean?
IMAC Holdings (BACK) has a Retained Earnings of $-72.38 Mil as of Sep. 2025. Retained earnings is the amount of net income not issued to shareholders. View historical data on IMAC Holdings and its competitors.
Is IMAC Holdings' Retained Earnings too high?
IMAC Holdings' current Retained Earnings is $-72.38 Mil.
How does IMAC Holdings' Retained Earnings compare to FCHS and NHLG?
IMAC Holdings' Retained Earnings of $-72.38 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Healthcare Providers & Services company?
A good Retained Earnings depends on the Healthcare Providers & Services industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on IMAC Holdings and its competitors. IMAC Holdings's current Retained Earnings is $-72.38 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IMAC Holdings stock overvalued right now?
IMAC Holdings (BACK) has a current Retained Earnings of $-72.38 Mil. The current Retained Earnings is $-72.38 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For IMAC Holdings (BACK), the current Retained Earnings is $-72.38 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

IMAC Holdings Business Description

Address 3401 Mallory Lane, Suite 100, Franklin, TN, USA, 37067
IMAC Holdings Inc is engaged in providing services related to proteomic products that identify and support oncology clinical treatment decisions and biopharmaceutical drug development. The Company has determined that it currently operates in a single segment, precision medicine in cancer treatment, located in a single geographic location, the United States.